Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for asymptomatic acute otitis media without perforation in Aboriginal children
ACTRN12608000424303Phase 4Recruiting
- Sponsor
- Menzies School of Health Research
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute otitis media (AOM) comparing Azithromycin with Placebo (2 arms). Primary endpoint: Clinical failure (all participants). Started Mar 2007; status: recruiting.
02
Drugs
azithromycin
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on ACTRN12608000424303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000424303.